optinose.com (OPTN): Net earnings per share growth forecast for next year
Sales of polyp sprays generate a steady cash flow for OptiNose, Inc. (OPTN), but high marketing expenses are weighing on free cash flow. The business relies on US-based manufacturing and the unique Exhalation Delivery System technology. Patent protection for XHANCE and stringent FDA regulations create significant barriers to entry. The trajectory of forward EPS estimates has reached 196.60, reflecting the analysts' consensus forecast.
Financial and market metric breakdowns for optinose.com (OPTN)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- net income and valuation ratios data:
OPTN - Net Financial Result|Projected Future Earnings OptiNose, Inc.|OPTN - Market Cap to Earnings|Projected Price to Earnings OptiNose, Inc.|OPTN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple OptiNose|OPTN - Operating income before deduction of amortization|Earnings per share for the last twelve months OptiNose|OPTN - Earnings per share for the last 12 months|Quarterly EPS earnings growth optinose.com|OPTN - Net earnings per share growth this year|Expected earnings per share growth for next year OptiNose, Inc.
- total revenue and sales volume data:
Initial company analysis:OPTN, Optinose
This indicator measures the consensus forecast for earnings per share (EPS) growth for the coming year, allowing investors to assess expected return dynamics relative to historical data. When analyzing the current valuation of OptiNose, Inc. (OPTN) EPS growth for the next year, it should be noted that for a non-cyclical business in the ENT sector, this metric reflects the effectiveness of insurance coverage expansion and marketing rather than market fluctuations.
Competing companies
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand LGND|Amneal Pharmaceuticals, Inc. (AMRX) - Expected net earnings per share growth next year|PRGO - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ALVO|LQDA (Liquidia Corporation) - Expected earnings per share growth for next year|GLPG: Projected earnings per share increase next year|ANIP (ANI Pharmaceuticals, Inc.) - Earnings growth forecast for next year|MannKind Corp (MNKD) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amphastar (AMPH)|Pacira Corp - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year ARS Pharmaceuticals SPRY|theravance.com (TBPH) - Expected net earnings per share growth next year|AQST - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year scPharmaceuticals Inc. SCPH|TECX: Earnings growth forecast for next year|Expected net earnings per share growth next year Tonix Pharmaceuticals Holding (TNXP)|Expected earnings per share growth for next year SXTC|EPRX: Expected earnings per share trend next year|Earnings growth forecast for next year BHST|Consensus forecast of earnings per share growth for next year Invizyne Technologies|Net earnings per share growth forecast for next year Oramed Pharmaceuticals Inc. ORMP|ENTX: Projected earnings per share growth rate for next year|MindWalk Holdings - Earnings growth forecast for next year|abvcpharma.com (ABVC) - Expected earnings per share growth for next year|CPIX (Cumberland Pharmaceuticals Inc.) - Expected earnings per share growth for next year|QNTM - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year FibroGen Corp|Expected net earnings per share growth next year Telomir Pharmaceuticals Corp TELO|Net earnings per share growth forecast for next year Rani Therapeutics (RANI)|SNYR: Net earnings per share change forecast for next year|Rallybio - Expected earnings per share growth for next year|Projected earnings per share increase next year LEXX (Lexaria Bioscience Corp)|PULM - Net earnings per share growth forecast for next year|PTHL (Pheton Holdings Ltd) - Projected earnings per share growth rate for next year|aptorumgroup.com (APM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year LYRA (lyratherapeutics.com)|IBO (Impact BioMedical Inc) - Earnings growth forecast for next year|TNFA: Expected earnings per share trend next year|Earnings growth forecast for next year YCBD|Earnings growth forecast for next year PainReform Corp (PRFX)|Net earnings per share growth forecast for next year Altamira Therapeutics Ltd. CYTO|Expected earnings per share trend next year LIPO|PIRS - Net earnings per share growth forecast for next year|Procaps Group (PROC) - Expected earnings per share growth for next year|PTPI: Earnings growth forecast for next year|Qilian International Corp (QLI) - Earnings growth forecast for next year|Expected earnings per share growth for next year SLRN|TFFP: Expected earnings per share trend next year
